Roivant Sciences Ltd. (ROIV)
41.43
+6.50
(+18.61%)
USD |
NASDAQ |
Sep 08, 15:59
41.30
-0.13
(-0.31%)
After-Hours: 20:00
Roivant Sciences Price to Book Value : 7.076 for Sept. 8, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 04, 2026 | 5.966 |
| September 03, 2026 | 5.877 |
| September 02, 2026 | 5.838 |
| September 01, 2026 | 5.896 |
| August 31, 2026 | 5.916 |
| August 28, 2026 | 5.928 |
| August 27, 2026 | 6.418 |
| August 26, 2026 | 6.277 |
| August 25, 2026 | 6.229 |
| August 24, 2026 | 6.21 |
| August 21, 2026 | 6.200 |
| August 20, 2026 | 6.292 |
| August 19, 2026 | 6.388 |
| August 18, 2026 | 6.382 |
| August 17, 2026 | 6.190 |
| August 14, 2026 | 6.183 |
| August 13, 2026 | 6.196 |
| August 12, 2026 | 6.176 |
| August 11, 2026 | 6.020 |
| August 10, 2026 | 6.111 |
| August 07, 2026 | 6.207 |
| August 06, 2026 | 5.998 |
| August 05, 2026 | 5.909 |
| August 04, 2026 | 5.908 |
| August 03, 2026 | 5.691 |
| Date | Value |
|---|---|
| July 31, 2026 | 5.792 |
| July 30, 2026 | 5.896 |
| July 29, 2026 | 5.614 |
| July 28, 2026 | 5.780 |
| July 27, 2026 | 5.930 |
| July 24, 2026 | 5.979 |
| July 23, 2026 | 5.995 |
| July 22, 2026 | 5.962 |
| July 21, 2026 | 5.971 |
| July 20, 2026 | 5.816 |
| July 17, 2026 | 5.894 |
| July 16, 2026 | 5.795 |
| July 15, 2026 | 5.959 |
| July 14, 2026 | 5.962 |
| July 13, 2026 | 5.894 |
| July 10, 2026 | 6.143 |
| July 09, 2026 | 6.287 |
| July 08, 2026 | 6.164 |
| July 07, 2026 | 6.202 |
| July 06, 2026 | 6.044 |
| July 02, 2026 | 6.000 |
| July 01, 2026 | 5.983 |
| June 30, 2026 | 6.044 |
| June 29, 2026 | 5.526 |
| June 26, 2026 | 5.421 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Oxford Biomedica Plc | -- |
| Bicycle Therapeutics Plc | 0.5712 |
| Arbutus Biopharma Corp. | 3.953 |
| Moderna, Inc. | 8.276 |
| Adaptimmune Therapeutics Plc | -- |
Price to Book Value Related Metrics
| PS Ratio | 4002.83 |
| Price | 41.43 |
| Earnings Yield | -1.06% |
| Market Cap | 29.94B |